ANKASCIN® 568-R Slide Show
2016 Taiwan-ASEAN Investment Strategy Partner Forum Held as Part of New Southbound Policy: Connect with ASEAN to Create New Business Opportunities
The Taiwan-ASEAN Investment Strategy Partner Forum, organized by the Ministry of Economic Affairs’s (MOEA) Department of Investment Services, was held at the Taipei International Conference Center today (the 13th).
Interview from PharmaBoardRoom: George J. Lee, Ph.D. – Chairman; Tzu-Ming Pan, Ph.D – Vice Chairman and Chief Technology and Science Officer, SunWay Biotech, Taiwan
George Lee and Tzu-Ming Pan introduce SunWay Biotech’s groundbreaking red yeast rice extract, ANKASCIN® 568-R, which has been recognized as a New Dietary Ingredient by the US FDA. SunWay Biotech is now bringing this unique product onto the global stage and are considering developing a pharmaceutical product based on the same compounds.